A fibroblast mitogen present in scleroderma but not control sera: Inhibition by proteinase inhibitors
- 1 January 1983
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 3 (1) , 35-38
- https://doi.org/10.1007/bf00541230
Abstract
Summary Fibroblast mitogenic activity (MA) has been identified in scleroderma (SD) sera. Control and scleroderma skin fibroblasts in early passage were observed for replication (cell counts) after 72 h of serum exposure. SD sera at 15% concentration induced a significant increase in control fibroblast numbers when compared with control sera; this effect was not seen with SD cells while at higher serum concentrations (30%); SD cells were slightly responsive to the MA. MA was completely abrogated by the proteinase inhibitors STI and TLCK which did not affect mitogens in healthy sera. Circulating mitogenic proteinases selective for fibroblasts could play a role in the fibrosis of SD by modulating fibroblast replication.Keywords
This publication has 9 references indexed in Scilit:
- Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors.Proceedings of the National Academy of Sciences, 1982
- Fibroblast selection in sclerodermaArthritis & Rheumatism, 1982
- Scleroderma (progressive systemic sclerosis)Arthritis & Rheumatism, 1981
- HUMAN MONOCYTE STIMULATION OF FIBROBLAST GROWTH BY A SOLUBLE MEDIATOR(S)1980
- SclerodermaJournal of Clinical Investigation, 1979
- Endothelial injury in scleroderma.The Journal of Experimental Medicine, 1979
- Progressive Systemic Sclerosis: Kidney InvolvementClinics in Rheumatic Diseases, 1979
- Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro A POSSIBLE DEFECT IN THE REGULATION OR ACTIVATION OF THE SCLERODERMA FIBROBLASTJournal of Clinical Investigation, 1974
- CONNECTIVE TISSUE SYNTHESIS BY SCLERODERMA SKIN FIBROBLASTS IN CELL CULTUREThe Journal of Experimental Medicine, 1972